Director, Jon and Jo Ann Hagler Center for Lymphoma Massachusetts General Hospital

Clinicn Investigator, Assc Prf MGBCI Faculty Heme Malig MGPO, Mass General Research Institute

Professor of Medicine Harvard Medical School

Associate Physician Medicine-Hematology and Medical Oncology, Massachusetts General Hospital

MD Mount Sinai School of Medicine 2000

antibodies monoclonal; antibodies neoplasm; antigens cd19; antineoplastic combined chemotherapy protocols; central nervous system neoplasms; chronic lymphocytic leukemia; diffuse; hodgkin disease; hodgkin lymphoma; leukemia prolymphocytic; lymphoid malignancies; lymphoma b-cell; lymphoma large b-cell; lymphoma non-hodgkin; lymphoma t-cell; murine-derived; splenomegaly; t-cell Dr. Abramson's clinical and research interests are in lymphoid malignancies, including all non-Hodgkin lymphomas (both B-cell and T-cell lymphomas), as well as Hodgkin lymphoma (also called Hodgkin's Disease), and Chronic Lymphocytic Leukemia (CLL).  His research involves identifying new targets for therapy in lymphomas and lymphoid leukemias, and the design and conduct of clinical trials of new cancer therapies in these diseases. He is a member of the American Society of Hematology, the American Society of Clinical Oncology, and a Fellow of the American College of Physicians.  Dr. Abramson is the author of numerous papers and book chapters on lymphoma, and lectures widely.